Komori
Immuno-Biological Laboratories (4570) · RiskRestated

Dependence on Small Organizations and Risk of Talent Attrition

First written in FY2016. 4 of 6 entries say "Restated". Latest entry: FY2025.

6entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY20202016: 120162017: 120172018: 020182019: 120192020: 120202021: 020212022: 020222023: 020232024: 120242025: 12025
Same theme, other companies
Labor Shortages and Strengthening Organizational Management SystemsA theme 211 companies write about · 211 as a headwind · 1 as a tailwind

98 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 199 companies compared. The sentences above are computed from all 199.Comparing 200 of the theme's 212 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2025RestatedAnnual report

    「Because the Group has few employees, the same employees work across multiple businesses.」

    Continues to disclose a small organization with 58 consolidated employees, in which the same employees work across multiple businesses.
  2. FY2024MaterialisedAnnual report

    「Because the Group has few employees, the same employees work across multiple businesses.」

    The consolidated employee count was 57, and the structure in which the same employees work across multiple businesses continued under the small-organization model. The filing also states that a shortage of personnel led to insufficient promotional activity in the cosmetics business, demonstrating the impact of personnel dependence on actual performance.
  3. FY2020RestatedAnnual report

    「President and Representative Director Seito Tsutomu (清藤 勉) has been the chief executive officer since the Group's founding and provides leadership in formulating and operating the business and carrying out development activities. The Group is also a small organization with limited human resources and therefore depends in part on the work of individual officers and employees.」

    Describes in greater detail the small organization and dependence on a specific individual and individual officers and employees, and states that the Group is working on delegating authority and segregating duties.
  4. FY2019RestatedAnnual report

    「The Group is a small organization. Although it is working to strengthen organizational responses, including internal controls, it remains small and has limited human resources, resulting in some dependence on the work of individual officers and employees.」

    Continues to disclose the risks of dependence on a small organization and human resources, employee attrition, and higher fixed costs resulting from rapid organizational expansion.
  5. FY2017RestatedAnnual report

    「As of the end of the consolidated fiscal year, the Group was a small organization with a total of 66 officers and employees, excluding temporary employees.」

    Identifies as risks the Group's small organization of 66 officers and employees, dependence on and attrition of individual officers and employees, and higher fixed costs resulting from rapid organizational expansion.
  6. FY2016First statedAnnual report

    「As of the end of the consolidated fiscal year, the Group was a small organization with a total of 64 officers and employees, excluding temporary employees.」

    Indicates that the Group is a small organization with 64 officers and employees and that dependence on individual officers and employees, as well as their departure, could disrupt operations.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Immuno-Biological Laboratories yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Dependence on Small Organizations and Risk of Talent Attrition | Immuno-Biological Laboratories Co.,Ltd. (4570) | Komori